Sorbitol

• Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and drink, partnered with Cryptobiotix, pioneers in preclinical gastrointestinal research, on the study.
• The doses of low and no calorie sweeteners used were based on actual intakes, regulations and amounts that are generally included in foods and beverages during different timepoints.
• Assessments of additional low and no calorie sweeteners, including allulose and erythritol, are being completed and details will be shared in due course.
• The low and no calorie sweeteners studied for this paper included: Acesulfame potassium (aceK), maltitol, sorbitol, stevia, sucralose and tagatose.

• Tate & Lyle and Cryptobiotix's breakthrough ex-vivo* study shows that sucralose does not impact the gut microbiota, while other low and no calorie sweeteners have potentially beneficial health effects
  LONDON, Feb. 8, 2024 /PRNewswire/ - A new, first-of-its-kind study has identified unique and potentially beneficial interactions between certain low and no calorie sweeteners, including stevia, and the human gut microbiota.
• The doses of low and no calorie sweeteners used were based on actual intakes, regulations and amounts that are generally included in foods and beverages during different timepoints.
• Assessments of additional low and no calorie sweeteners, including allulose and erythritol, are being completed and details will be shared in due course.
• The low and no calorie sweeteners studied for this paper included: Acesulfame potassium (aceK), maltitol, sorbitol, stevia, sucralose and tagatose.

• The global market for Polyol Sweeteners is undergoing significant growth, with the industry expected to flourish in the coming years.
• Independent analysis reveals substantial market potential across various geographic regions, offering valuable insights into past, present, and future trends.
• With applications ranging from Food & Beverage to Personal Care & Cosmetics, Pharmaceuticals, and more, the Polyol Sweeteners market is poised for impressive growth.
• The Polyol Sweeteners market in the U.S. is estimated at US$1.2 Billion in the year 2022.

• The World Health Organization declared on July 14, 2023, that the widely used synthetic sweetener aspartame could be a “possible” carcinogen, or cancer-causing agent, on the basis of “limited evidence for cancer in humans.” But the agency also concluded that the currently available data does not warrant a change of the acceptable daily intake of aspartame at this time.
• The Conversation asked chronic disease epidemiologist Paul D. Terry, public health scholar Jiangang Chen and nutrition expert Ling Zhao, all from the University of Tennessee, to put these seemingly contradictory findings into perspective based on the available scientific evidence.

1. Why is aspartame being classified as ‘possibly’ cancer-causing?

• Because it is approximately 200 times sweeter than table sugar, smaller amounts of aspartame are added to foods, and they contribute considerably fewer calories.
• NutraSweet and Equal are well-known brand names for aspartame sold in packages for individual use.
• The International Agency for Research on Cancer, an entity within the WHO, evaluated findings from both human and animal studies of aspartame and cancer.

2. What are the current guidelines for aspartame consumption?

• This amount of aspartame per day translates to approximately eight to 12 cans of soda, or approximately 60 packets of aspartame, for a person weighing 132 pounds (60 kilograms).
• For a child weighing 33 pounds (15 kg), it translates to between two to three cans of aspartame-sweetened soda per day, or approximately 15 packets of aspartame.

3. Does the WHO’s new stance change that recommendation?

• Independently of the expert panel on cancer, the food safety group also evaluated the available evidence and concluded that there was no “convincing evidence” from either animal or human studies that aspartame consumption causes adverse effects within the currently established daily limits.
• It is important to note that people with the rare inherited disorder called phenylketonuria, or PKU, should avoid or restrict aspartame intake.

4. How can two consensus groups reach different conclusions?

• It is not uncommon for scientific consensus groups to differ in how they classify risk based on the results of published studies, even if more than one of those consensus groups is affiliated with the same agency or parent organization.
• Whereas the WHO’s expert cancer group’s stance may appear to be more worrisome than that of the committee on food safety, in fact, the latter’s “no convincing evidence” is consistent with the cancer group’s “limited evidence” classification.

5. How does aspartame compare to other sweeteners?

• But, like aspartame, many of these sweeteners have been implicated in developing cancer.
• This list includes acesulfame potassium, or Ace-K – a synthetic calorie-free sugar substitute – as well as sugar alcohols and even simple sugar.

6. So what should consumers do?

• And, as noted by the Mayo Clinic, artificial sweeteners may play a beneficial role for some people who are seeking to manage their weight or control their sugar intake.
• One thing is clear: Scientific studies on aspartame consumption will continue, and it will be important for both consumers and the research community to continue weighing potential risks.